Syphilis control efforts jeopardized by penicillin injection recall
A recent recall of injected penicillin has raised alarms among public health officials, medical professionals, and community organizations dedicated to controlling sexually transmitted infections. The recall, which affects a specific batch of injectable penicillin used primarily to treat syphilis, could undermine recent progress in combating a disease that has seen a troubling resurgence in recent years.Penicillin G benzathine, widely recognized by the brand name Bicillin L-A, is the premier treatment for syphilis, especially in expectant women, where it serves an essential function in thwarting congenital syphilis—a condition transmitted from the mother to the infant during pregnancy. The safety and efficacy…